Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YTH domain family, member 1 pseudogene (ENSG00000277881) is a processed pseudogene that is homologous to the protein-coding gene YTHDF1. As a pseudogene, it does not produce a functional protein product and is generally not considered a drug target. Pseudogenes are non-functional genomic sequences derived from ancestral genes, often disrupted by mutations. While some pseudogenes can act as regulatory non-coding RNAs (for example, by acting as competitive endogenous RNAs and modulating the expression of their parental genes or related pathways), there is no evidence that this specific pseudogene plays a prominent therapeutic or diagnostic role. It should not be confused with the functional YTHDF1 protein, which is involved in RNA binding and m^6A RNA modification signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YTH domain family, member 1 pseudogene.